AxoGen (AXGN) News Today $9.75 -0.29 (-2.89%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$10.01 +0.26 (+2.67%) As of 06/13/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AXGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Assenagon Asset Management S.A. Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN)Assenagon Asset Management S.A. lifted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 21.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,001,217 shares of the medical equipment provider's stock after buJune 14 at 4:21 AM | marketbeat.comFY2025 EPS Estimates for AxoGen Reduced by Cantor FitzgeraldJune 6, 2025 | americanbankingnews.comCantor Fitzgerald Reaffirms Their Buy Rating on AxoGen (AXGN)June 5, 2025 | theglobeandmail.comAxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Buy" from AnalystsJune 5, 2025 | americanbankingnews.comAxoGen, Inc. (NASDAQ:AXGN) Short Interest UpdateAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 2,020,000 shares, an increase of 21.0% from the April 30th total of 1,670,000 shares. Approximately 4.9% of the company's shares are sold short. Based on an average daily volume of 621,900 shares, the short-interest ratio is presently 3.2 days.June 4, 2025 | marketbeat.comCantor Fitzgerald Analysts Cut Earnings Estimates for AxoGenAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Stock analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for AxoGen in a research note issued to investors on Monday, June 2nd. Cantor Fitzgerald analyst R. Osborn now anticipates that the medical equipment provider will post earnings of (June 4, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Squarepoint Ops LLCSquarepoint Ops LLC grew its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 86.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 55,668 shares of the medical equipment provider's stock after acquiring an additional 25June 2, 2025 | marketbeat.comMillennium Management LLC Lowers Position in AxoGen, Inc. (NASDAQ:AXGN)Millennium Management LLC cut its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 88.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 131,182 shares of the medical equipment providerJune 2, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Buy" from BrokeragesShares of AxoGen, Inc. (NASDAQ:AXGN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the five ratings firms that are currently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year price objective amongJune 1, 2025 | marketbeat.comJane Street Group LLC Sells 30,670 Shares of AxoGen, Inc. (NASDAQ:AXGN)Jane Street Group LLC decreased its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 53.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,446 shares of the medical equipmentJune 1, 2025 | marketbeat.comAxogen, Inc to Participate at Goldman Sachs Global Healthcare ConferenceMay 28, 2025 | globenewswire.comBank of America Corp DE Reduces Stake in AxoGen, Inc. (NASDAQ:AXGN)Bank of America Corp DE lowered its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 17.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 402,523 shares of the medical equipment provider's stock after sellMay 28, 2025 | marketbeat.comAmeriprise Financial Inc. Has $4.81 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Ameriprise Financial Inc. grew its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 86.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 291,590 shares of the medical equipment provider's stock after buying aMay 26, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Director Joseph A. Tyndall Sells 20,062 SharesMay 24, 2025 | insidertrades.comAxoGen, Inc. (NASDAQ:AXGN) is Soleus Capital Management L.P.'s 7th Largest PositionSoleus Capital Management L.P. lowered its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 1.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,955,943 shares of the medical equipment provider's stock after selling 5May 21, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN)Jacobs Levy Equity Management Inc. grew its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 39.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,000 shares of thMay 19, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 146,038 Shares of AxoGen, Inc. (NASDAQ:AXGN)D. E. Shaw & Co. Inc. decreased its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 23.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 488,306 shares of the medical equipment provider's stock after seMay 18, 2025 | marketbeat.comCubist Systematic Strategies LLC Sells 101,445 Shares of AxoGen, Inc. (NASDAQ:AXGN)Cubist Systematic Strategies LLC lowered its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 70.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,168 shares of the medical equipment prMay 18, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Position Lessened by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC reduced its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 365,703 shares of the medical equipment provider's sMay 16, 2025 | marketbeat.comNicholas Investment Partners LP Has $4.87 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Nicholas Investment Partners LP raised its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 49.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 295,554 shares of the medical equipment pMay 16, 2025 | marketbeat.comWhat Analysts Are Saying About Axogen StockMay 15, 2025 | nasdaq.comAxoGen (NASDAQ:AXGN) Price Target Lowered to $24.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their price objective on AxoGen from $26.00 to $24.00 and set a "buy" rating for the company in a report on Tuesday.May 15, 2025 | marketbeat.comAxoGen FY2025 EPS Estimate Reduced by Cantor FitzgeraldAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Research analysts at Cantor Fitzgerald dropped their FY2025 earnings estimates for AxoGen in a research report issued on Monday, May 12th. Cantor Fitzgerald analyst R. Osborn now expects that the medical equipment provider will post earnings per share ofMay 15, 2025 | marketbeat.com2AXGN : What Analysts Are Saying About Axogen StockMay 13, 2025 | benzinga.comBalyasny Asset Management L.P. Acquires New Shares in AxoGen, Inc. (NASDAQ:AXGN)Balyasny Asset Management L.P. acquired a new position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 299,942 shares of the medical equipment provider's stock, valued at approximMay 13, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPSAxoGen (NASDAQ:AXGN - Get Free Report) announced its quarterly earnings data on Thursday. The medical equipment provider reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.07). AxoGen had a negative net margin of 7.91% and a negative return on equity of 14.91%.May 12, 2025 | marketbeat.comDimensional Fund Advisors LP Raises Stake in AxoGen, Inc. (NASDAQ:AXGN)Dimensional Fund Advisors LP increased its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 772,752 shares of the medical equipment provider's stock afterMay 12, 2025 | marketbeat.comDriehaus Capital Management LLC Raises Stake in AxoGen, Inc. (NASDAQ:AXGN)Driehaus Capital Management LLC lifted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 166.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 954,439 shares of the medical equipment provider'May 11, 2025 | marketbeat.comAxogen, Inc.'s (NASDAQ:AXGN) Intrinsic Value Is Potentially 87% Above Its Share PriceMay 10, 2025 | finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by DAFNA Capital Management LLCDAFNA Capital Management LLC lowered its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 9.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 846,882 shares of the medical equipment provider's stock after selling 89,012 shares during the period. AxoGen accoMay 10, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Decreases Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Schonfeld Strategic Advisors LLC lowered its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 77.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 63,300 shares of the medical equipment provider's stock afteMay 10, 2025 | marketbeat.comAxogen, Inc. (AXGN) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comAxogen names Lindsey Hartley as finance chiefMay 9, 2025 | seekingalpha.comAxogen Announces Chief Financial Officer TransitionMay 9, 2025 | finance.yahoo.comAxogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ...May 9, 2025 | finance.yahoo.comAxogen, Inc. Reports 2025 First Quarter Financial ResultsMay 8, 2025 | globenewswire.comBosun Asset Management LLC Buys 44,810 Shares of AxoGen, Inc. (NASDAQ:AXGN)Bosun Asset Management LLC boosted its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 125.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 80,448 shares of the medical equipment provider's stock after buying an adMay 8, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Recommendation of "Buy" from BrokeragesAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) has been assigned an average recommendation of "Buy" from the five analysts that are covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that haveMay 8, 2025 | marketbeat.comTudor Investment Corp ET AL Sells 24,801 Shares of AxoGen, Inc. (NASDAQ:AXGN)Tudor Investment Corp ET AL reduced its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 22.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 87,551 shares of the medical equipment provider's stock after selling 24,8May 8, 2025 | marketbeat.comAxoGen Q1 2025 Earnings PreviewMay 7, 2025 | msn.comAquatic Capital Management LLC Lowers Stake in AxoGen, Inc. (NASDAQ:AXGN)Aquatic Capital Management LLC lessened its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 74.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,220 shares of the medical equipment provider's stock after sellingMay 7, 2025 | marketbeat.comRenaissance Technologies LLC Acquires New Stake in AxoGen, Inc. (NASDAQ:AXGN)Renaissance Technologies LLC acquired a new position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 22,000 shares of the medical equipment provider's stock, valued at appMay 6, 2025 | marketbeat.comInvesco Ltd. Has $283,000 Stock Position in AxoGen, Inc. (NASDAQ:AXGN)Invesco Ltd. lessened its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 93.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,192 shares of the medical equipment provider's stock after selling 260,29May 6, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Position Decreased by ArrowMark Colorado Holdings LLCArrowMark Colorado Holdings LLC reduced its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 1.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,248,792 shares of the medical equipment provMay 5, 2025 | marketbeat.comMarshall Wace LLP Sells 18,763 Shares of AxoGen, Inc. (NASDAQ:AXGN)Marshall Wace LLP decreased its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 17.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 91,591 shares of the medical equipment provider's stock aMay 1, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Stock Holdings Lifted by First Light Asset Management LLCFirst Light Asset Management LLC raised its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 10.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,506,795 shares of the medical equipment provider's stock after purchasingApril 30, 2025 | marketbeat.comXTX Topco Ltd Acquires Shares of 17,306 AxoGen, Inc. (NASDAQ:AXGN)XTX Topco Ltd bought a new position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 17,306 shares of the medical equipment provider's stock, valued at approximately $285,000. Other large investors haApril 28, 2025 | marketbeat.comRaymond James Financial Inc. Invests $4.55 Million in AxoGen, Inc. (NASDAQ:AXGN)Raymond James Financial Inc. bought a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 276,200 shares of the medical equipment provider's stock,April 28, 2025 | marketbeat.comOberweis Asset Management Inc. Has $4.95 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Oberweis Asset Management Inc. increased its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 31.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 300,500 shares of the medical equipment provider's stockApril 27, 2025 | marketbeat.comAxoGen (AXGN) Projected to Post Earnings on ThursdayAxoGen (NASDAQ:AXGN) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-axogen-inc-stock/)April 26, 2025 | marketbeat.com Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address AXGN Media Mentions By Week AXGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼1.890.88▲Average Medical News Sentiment AXGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼24▲AXGN Articles Average Week Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVCR News LMAT News ENOV News CNMD News EYE News LQDA News CDRE News TNDM News AORT News PLSE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
